欢迎来到西安迈博睿(Mabioway)生物科技有限公司 Call: 15339069646 | E-mail: info@mabioway.cn 在线留言 |

服务热线

15339069646
网站导航
当前位置: 首页 > 产品展示 > 抗体产品 > 一抗 > 其他抗体
其他抗体
Anti-LASV glycoprotein complex mAbs [25.10C](MABL-4001)
  • Anti-LASV glycoprotein complex mAbs [25.10C](MABL-4001)

Anti-LASV glycoprotein complex mAbs [25.10C](MABL-4001)

简要描述:

For Research Use Only. Not for diagnostic or therapeutic use.

产品参数:

Cat. No.:MABL-4001

Application:cryoEM, in vitro, neutralization, ELISA

Isotype:Engineer antibody

Species Reactivity:Lassa virus (LASV)

Clone No.:25.10C

产品价格:¥0

详细介绍
Cat. No.
MABL-4001
Application
cryoEM, in vitro, neutralization, ELISA
Isotype
Engineer antibody
Species Reactivity
Lassa virus (LASV)
Clone No.
25.10C
From
Recombinant Antibody
Specificity
This antibody is specific for the LASV glycoprotein complex (GPC) from all LASV lineages (I–IV). It binds the GPC‑A epitope, a neutralizing site spanning GP1 and GP2 subunits within a single protomer. No cross‑reactivity with other Old World arenaviruses such as LCMV or LUJV.
Alternative Names
Lassa virus glycoprotein complex; GPC; Pre‑glycoprotein polyprotein GP complex; Pre‑GP‑C; Stable signal peptide; SSP; Glycoprotein G1; GP1; Glycoprotein G2; GP2
UniProt
P08669
Immunogen
The original antibody was generated from the B cells of a human survivor of Lassa fever.
Application Notes
Specific recognition of LASV GPC confirmed by ELISA. Potently neutralizes all four LASV lineages in pseudovirus assays and PRNT (Robinson et al., 2016; PMID:27161536). Cryo‑EM reveals neutralization mechanism: heavy chain contacts GP1 LAMP1‑binding loop, light chain anchors GP2 fusion loop, blocks GP‑LAMP1 interaction to inhibit viral membrane fusion and infection. BLI shows high affinity: KD 3.52 nM (LI GP), 36.1 pM (LI‑R95M‑GP), 1.00 pM (LIV GP) (Buck et al., 2022; PMID:35730904). Neutralizing activity is unaffected by seven GPC glycan‑knockout mutants. Fab binds fully‑cleaved prefusion GPC trimer verified by NS‑EM (Li et al., 2022; PMID:36288283). Used as positive control in pseudovirus neutralization assay; achieves near‑complete neutralization of wild‑type ppLASV (Josiah strain) at 1 μg/ml (Enriquez et al., 2025; PMID:40168843). First published in Nat Commun, 2016, paper characterizes human mAbs from Lassa‑fever survivors targeting LASV glycoproteins.
Antibody First Published
Robinson et al. Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits Nat Commun. 2016 May 10:7:11544. doi: 10.1038/ncomms11544. PMID:27161536
Note on publication
Robinson et al. Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits Nat Commun. 2016 May 10:7:11544. doi: 10.1038/ncomms11544. PMID:27161536
Size
100 μg Purified antibody.
Concentration
1 mg/ml.
Purification
Protein A affinity purified
Buffer
PBS with 0.02% Proclin 300.
Storage Recommendation
Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C.

 


服务咨询

留言框

  • 标题:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

推荐产品

联系我们

Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有

地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层

电话:15339069646 邮箱:info@mabioway.cn

陕ICP备2021006339号